Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: Comparison with four other melanoma markers

American Journal of Surgical Pathology

Volumn 25, Issue 2, 2001, Pages 205-211

  Miettinen, Markku ^a   Fernandez, Martin ^b   Franssila, Kaarle ^c   Gatalica, Zoran ^b   Lasota, Jerzy ^a   Sarlomo Rikala, Maarit ^d  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Immunohistochemistry; Melan A; Tyrosinase

Indexed keywords

MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; NUCLEAR PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOMA; METASTASIS; PROTEIN EXPRESSION;

ANGIOMYOLIPOMA; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; DNA-BINDING PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HISTIOCYTES; HUMANS; LYMPHANGIOMYOMA; MELANOMA; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035110077     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200102000-00008     Document Type: Article

References (38)

1. HMB-45: A review
2. Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes
3. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB45 in malignant melanoma and melanoma variants
4. Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors
5. Xanthogranulomas with inconspicuous foam cells and giant cells mimicking malignant melanoma
6. KP-1: Not a specific marker: Staining of 137 sarcomas, 48 lymphomas, 28 carcinomas, 7 malignant melanomas and 8 cystosarcoma phyllodes
7. Immunophenotyping of melanomas for tyrosinase: Implications for vaccine development
8. S-100 protein immunore-activity in poorly differentiated carcinomas: Immunohistochemical comparison with malignant melanoma
9. Comparison of melanoma antigen recognized by T-cells (MART-1) to HMB-45: Additional evidence to support a common lineage for angiomyolipoma, lymphangiomyomatosis and clear cell sugar tumor
10. Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations from melanocytes
11. Microphthalmia, a critical factor in melano-cyte development, defines a discrete transcription factor family
12. S100 protein expression by primary and metastatic adenocarcinomas
13. Tyrosinase immunoreactivity in formalin-fixed, paraffin embedded primary and metastatic melanoma: Frequency and distribution
14. A103: An anti melan-A monoclonal antibody for the detection of malignant melanoma in paraffin embedded tissues
15. Expression of melanocyte-associated markers gp-100 and Melan-A/MART-1 in angiomyolipomas: An immunohistochemical and RT-PCR analysis
16. Melanocyte-associated markers A103, T311, HMB45, and D5 in angiomyolipomas: A comparison
17. T311: An anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin-embedded tissues
18. Role of antibody to S100 protein in diagnostic pathology
19. Production of recombinant MART-1 proteins and specific anti MART-1 polyclonal and monoclonal antibodies: Use in the characterization of the human melanoma antigen MART-1
20. Tyrosinase, melan-A and KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanomas on paraffin sections
21. Microphthalmia transcription factor: A sensitive and specific melanocytic marker for melanoma diagnosis
22. Metastatic malignant melanoma resembling malignant peripheral nerve sheath tumor: Report of 16 cases
23. Melanoma cell adhesion molecule (Mel-CAM, CD146) and microphthalmia transcription factor (MiTF) expression distinguish desmoplastic/sarcomatoid melanoma (DM) from morphological mimics
24. Immunohistochemical demonstration of the lysosome-associated glycoprotein CD68 (KP1) in granular cell tumors and schwannomas
25. Metastases of malignant melanoma simulating soft tissue sarcoma: A clinicopathological, light and electron microscopic and immunohistochemical study of 21 cases
26. Desmoplastic and spindle-cell malignant melanoma: An immunohistochemical study
27. CD68: Its limited specificity for histiocytic tumors
28. Translocation t(12;22)(q13;q12.2-12.3) in a clear cell sarcoma of tendons and aponeuroses
29. Morphologic diversity in malignant melanomas
30. Comparison of HMB45 monoclonal antibody and S100 protein in the immunohistochemical diagnosis of melanoma
31. Melan-A/MART-1 expression in various melanocytic lesions and in nonmelanocytic soft tissue tumours
32. Monoclonal antibody MAT-1 can detect melanogenic cells on formalin-fixed paraffin-embedded sections
33. Alpha-1-antitrypsin and lysozyome: Their limited significance in fibrohistiocytic tumors
34. S100 protein in soft tissue tumours derived from schwann cell and melanocytes
35. Molecular basis of mouse microphthalmia (mi) mutations helps in explaining their developmental and phenotypic consequences
36. Clear cell sarcoma: An immunohistochemical analysis of six cases and comparison with other epithelioid neoplasms of soft tissue
37. Age-resolving osteopetrosis: A rat model implicating microphthalmia and the related transcription factor TEF3
38. Microphthalmiaassociated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene